Showing results (271-280 of 280) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 280 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
ESMO Open|May 14, 2024
Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110)M Boukovala, D P Modest, I Ricard, et al.
Breast Cancer Research and Treatment|April 6, 2013
International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastasesTuomo J Meretoja, R A Audisio, P S Heikkilä, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2016
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)M Michl, S Stintzing, L Fischer von Weikersthal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2013
The requirements of a specialist Breast CentreA R M Wilson, L Marotti, S Bianchi, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2007
Guidelines on the standards for the training of specialised health professionals dealing with breast cancerL Cataliotti, C De Wolf, R Holland, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitisMarisa J Brothwell, Guoshen Cao, J Alan Maschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Nature|November 13, 2024
Biodiversity impacts of the 2019-2020 Australian megafiresDon A Driscoll, Kristina J Macdonald, Rebecca K Gibson, et al.
Pageof 28